Approximately 20 percent of the population suffers from the experts as seasonal allergic rhinitis designated disease. It belongs to the atopic diseases and is associated with an increased production of IgE - accompanied antibodies, the inflammation in the nasal mucous cause. Consequences are next to the attraction cough, itching and the secretion, including the blockage of the nose, medically as obstruction.
The disease is not only genetic factors - environmental factors also play an important role. Thus, especially the industrial nations affected, while the countries in the third world is suffering from allergies. The reason for this is the high hygiene standard and the gains in the quality of life compared to the developing countries.
When the initial contact with potential allergens (substances that cause allergies), it is not yet described to the inflammatory reactions. Rather, these phagocytosis system of the human body recognized and the immune system. The phagocytosis system is represented by the macrophages, also known as macrophages; there are unknown substances from the human body to eliminate them.
The immune system is then able antibodies against the unknown substance to form and a repeated contact with the protection of human release.
A chronic course of the disease carries the risk of complications and long-term consequences: in addition to changes in the nasal mucosa can also be a disturbance of the olfactory Inns occurs. It is an urgent need for consistent treatment, domestic funds are inappropriate. In addition to the H 1-antihistamines and glucocorticoids, it’s been a few years, you can Hyposensibilisierung. It is the parties concerned allergen substrate in increasing dosage injected. If the maximum dose achieved, followed by another three years in which the immunotherapy will continue.
Despite all the achievements so far there is still much to be done in therapy - that also affected the spring is concerned.